Brief: Allarity Therapeutics Receives Notice Of Delisting From Nasdaq
21/12/2022 14:19
Dec 21 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ON DEC 20, CO RECEIVED NOTICE OF DELISTING OR FAILURE TO
SATISFY
A CONTINUED LISTING RULE OR STANDARD FROM NASDAQ
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic